Clinakos

Transforming Lifesciences with NLP

Clinakos, Pharmaceuticals, Rare Diseases, NLP, AI, Medically Smart AI, Patient Data

According to Gramener, a Gartner-recognized company, Natural Language Processing (NLP) is projected to add $4.3 billion in revenue to the healthcare market by 2026. Clinakos Inc.‘s Medically Smart AI™ leverages NLP and Machine Learning (ML) to ignite innovation and improve patient outcomes. Our AI-driven insights are backed by advanced data science techniques, refined on vast real-world patient data sets over the last 10 years.

Clinakos’ Solution’s NLP features :
🔸Clinakos’s Medically Smart AI™: Leading the charge in life sciences innovation with NLP and ML.
🔸AI-Enabled Insights: Harnessing advanced AI and data science for smarter decision-making and superior patient outcomes.
🔸Proprietary AI/ML Models: Perfected using extensive real-world patient data.

Discover more about our solutions at https://lnkd.in/gc65nwja

Scroll to Top

Connect with us